1993
DOI: 10.1016/0922-4106(93)90134-u
|View full text |Cite
|
Sign up to set email alerts
|

Direct inhibition of platelet function by organic nitrates via nitric oxide formation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
23
0
2

Year Published

1995
1995
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 58 publications
(26 citation statements)
references
References 26 publications
1
23
0
2
Order By: Relevance
“…The cGMP levels of washed platelets was determined in supernatants after neutralization with bicarbonate (24) using a radioimmunassay (cGMP [ 125 I] RIA Kit; BioTrend, Cologne, Germany; reference 23). To determine cGMP content in phosphodiesterase-inhibited platelets, cells were incubated with 20 M zaprinast for 10 min (25).…”
Section: Methodsmentioning
confidence: 99%
“…The cGMP levels of washed platelets was determined in supernatants after neutralization with bicarbonate (24) using a radioimmunassay (cGMP [ 125 I] RIA Kit; BioTrend, Cologne, Germany; reference 23). To determine cGMP content in phosphodiesterase-inhibited platelets, cells were incubated with 20 M zaprinast for 10 min (25).…”
Section: Methodsmentioning
confidence: 99%
“…increasing the blood flow to the developing placenta. NO also inhibits the aggregation and adhesion of platelets (Weber et al, 1993). The local production of NO may be critical to the prevention of thrombus formation within the placenta.…”
Section: Discussionmentioning
confidence: 99%
“…eNOS inhibition increases platelet aggregability, whereas NO donors such as nitrates are potent anti-aggregant drugs [35,36,37]. Therefore, we measured the in vitro bleeding time to assess the platelet L -arginine/NO pathway and hence to test whether or not statins upregulate the activity of this pathway in humans at clinically relevant doses.…”
Section: Discussionmentioning
confidence: 99%